卖了200多元被罚2000元，扬州查处一起“回流药”案件

Core Viewpoint - The article highlights a case of illegal drug sales in Yangzhou, emphasizing the importance of drug safety and the need for strict regulatory compliance in the pharmaceutical industry [1][2]. Group 1: Case Details - The Yangzhou Guangling District Market Supervision Administration exposed a case involving a clinic that sold two boxes of Fufang Danshen Diwan and several boxes of Shexiang Baoxinwan without proper procurement documentation [1]. - The clinic was fined 2,000 yuan and had its illegal gains confiscated due to its initial offense and cooperation with the investigation [1]. Group 2: Regulatory Implications - The case serves as a warning to drug-use units to strictly implement procurement systems and standardize supply channels, reflecting the market supervision department's zero-tolerance policy towards "reflow drugs" [2]. - "Reflow drugs" refer to medications that are purchased through insurance and then illegally resold, posing significant safety risks due to improper storage and potential adulteration [2]. Group 3: Consumer Guidance - The market supervision department advises consumers to check the traceability codes on drug packaging, which serve as an "electronic ID" to ensure the legitimacy of the product [2]. - Consumers are cautioned against purchasing drugs from unknown sources or those with damaged packaging, and not to sell expired medications to drug dealers [2].